OPA1 and glaucoma: Finally, the glaucoma inductors were able to degrade retinal tissue (p < 0.05), but VGLCR pre-treatment was able to counteract this process (p < 0.05) by overexpressing OPA1 better than the post-stimulation (p < 0.05, about 50%), confirming its protective role (Figure 7D,E).